Literature DB >> 21725199

Lymphovascular invasion of colorectal cancer is correlated to SPARC expression in the tumor stromal microenvironment.

Tetsunori Yoshimura1, Makoto Nagahara, Christine Kuo, Roderick R Turner, Patrick Soon-Shiong, Dave S B Hoon.   

Abstract

As an integral component of the microenvironment in colorectal cancer (CRC), stromal cells can influence tumor progression. Found in the extracellular matrix of CRC, secreted protein acidic and rich in cysteine (SPARC) is expressed in stromal and CRC cells. While SPARC's influence on CRC is not clear, we hypothesized that epigenetically regulated SPARC expression in the microenvironment stromal cells of CRC can affect primary CRC progression and is influenced by lymphovascular invasion (LVI). Quantitative immunohistochemistry (IHC) analysis of paraffin-embedded (n=72) from 37 LVI-positive and 35 LVI-negative primary CRCs was performed. MassARRAY sequencing was performed to assess the methylation status of the promoter region in 22 LVI-positive and 20 LVI-negative CRC and to identify specific CpG island(s) regulating SPARC expression. SPARC in CRC cells was not correlated with LVI, whereas SPARC in the microenvironment stromal cells was inversely related to LVI (P < 0.0001). There was a direct relationship between LVI and 6 specific CpG site methylation in the SPARC promoter region of stromal cells (P = 0.017) but not in CRC cells. Stromal SPARC expression inversely correlated with VEGF-A expression in CRC (P = 0.003) and positively correlated with HSP27 expression (P = 0.009). The results suggested that the epigenetic regulation of SPARC expression in tumor cells versus stromal cells of CRC is significantly different. Stromal cell SPARC expression is epigenetically influenced by LVI of CRC tumors, and may play a significant role in primary CRC progression.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21725199     DOI: 10.4161/epi.6.8.16063

Source DB:  PubMed          Journal:  Epigenetics        ISSN: 1559-2294            Impact factor:   4.528


  12 in total

1.  Heterogeneous epigenetic regulation of TIMP3 in prostate cancer.

Authors:  Toshiaki Shinojima; Qiang Yu; Sharon K Huang; Michelle Li; Ryuichi Mizuno; Edison T Liu; Dave S B Hoon; Laurent Lessard
Journal:  Epigenetics       Date:  2012-09-28       Impact factor: 4.528

2.  Epigenetic regulation of REG1A and chemosensitivity of cutaneous melanoma.

Authors:  Yusuke Sato; Diego M Marzese; Katsuya Ohta; Sharon K Huang; Myung Shin Sim; Kelly Chong; Dave S B Hoon
Journal:  Epigenetics       Date:  2013-07-31       Impact factor: 4.528

3.  Loss of SPARC in bladder cancer enhances carcinogenesis and progression.

Authors:  Neveen Said; Henry F Frierson; Marta Sanchez-Carbayo; Rolf A Brekken; Dan Theodorescu
Journal:  J Clin Invest       Date:  2013-01-16       Impact factor: 14.808

Review 4.  Genetic and epigenetic biomarkers for diagnosis, prognosis and treatment of colorectal cancer.

Authors:  Fabio Coppedè; Angela Lopomo; Roberto Spisni; Lucia Migliore
Journal:  World J Gastroenterol       Date:  2014-01-28       Impact factor: 5.742

Review 5.  Heat shock proteins and heat shock factor 1 in carcinogenesis and tumor development: an update.

Authors:  Daniel R Ciocca; Andre Patrick Arrigo; Stuart K Calderwood
Journal:  Arch Toxicol       Date:  2012-08-11       Impact factor: 5.153

Review 6.  Biomarkers for predicting future metastasis of human gastrointestinal tumors.

Authors:  Lui Ng; Ronnie Tung Ping Poon; Roberta Pang
Journal:  Cell Mol Life Sci       Date:  2013-01-31       Impact factor: 9.261

7.  Aberrant expression of long noncoding RNAs in colorectal cancer with liver metastasis.

Authors:  Le-chi Ye; Li Ren; Jun-jun Qiu; De-xiang Zhu; Tao Chen; Wen-ju Chang; Shi-xu Lv; Jianmin Xu
Journal:  Tumour Biol       Date:  2015-06-07

8.  Aberrant methylation of SPARC in human hepatocellular carcinoma and its clinical implication.

Authors:  Ye Zhang; Bin Yang; Zhi Du; Tong Bai; Ying-Tang Gao; Yi-Jun Wang; Cheng Lou; Feng-Mei Wang; Yu Bai
Journal:  World J Gastroenterol       Date:  2012-05-07       Impact factor: 5.742

9.  AIM1 and LINE-1 epigenetic aberrations in tumor and serum relate to melanoma progression and disease outcome.

Authors:  Sojun Hoshimoto; Christine T Kuo; Kelly K Chong; Teh-Ling Takeshima; Yoshiki Takei; Michelle W Li; Sharon K Huang; Myung-Shin Sim; Donald L Morton; Dave S B Hoon
Journal:  J Invest Dermatol       Date:  2012-03-08       Impact factor: 8.551

10.  B7-H3 associated with tumor progression and epigenetic regulatory activity in cutaneous melanoma.

Authors:  Jinhua Wang; Kelly K Chong; Yoshitaka Nakamura; Linhda Nguyen; Sharon K Huang; Christine Kuo; Wang Zhang; Hua Yu; Donald L Morton; Dave S B Hoon
Journal:  J Invest Dermatol       Date:  2013-03-08       Impact factor: 8.551

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.